FDA's Oncologic Drugs Advisory Committee reviewed the sBLA for glofitamab + GemOx today. STARGLO trial showed a 41% OS benefit in transplant-ineligible R/R DLBCL, with implications for care delivery for pharmacists. FDA sBLA decision expected July 2025. shorturl.at/J79IY #OncologyPharmacy #DLBCL

NCCN has released updates to breast cancer guidelines Version 4.2025 as of April 30, 2025. Changes include revised indications (olaparib, capecitabine) and new sequencing flexibility (taxane before anthracycline), as well as other updates. #breastcancer #NCCN shorturl.at/9yPPW

NCCN’s 2025 Colon Cancer Guidelines now support DPYD genotyping before fluoropyrimidine chemotherapy. Pharmacists are key to enacting this guideline through leading testing efforts and educating patients on their options. shorturl.at/t3qT7 #Pharmacogenetics #DPYD #NCCN #PrecisionMedicine

Call for submissions: Practice and Paradox Pharmacy Practice in Focus: Oncology is looking for submissions to our Practice and Paradox column—where we explore the tension between the calling of health care and the system-level and financial realities of the field. #OncologyPharmacy

NCCN has updated Version 3.2025 of their EEJC guidelines for squamous cell carcinoma. Tislelizumab-based combos (with oxaliplatin or cisplatin + paclitaxel) are now preferred first-line options for PD-L1 CPS ≥1. New dosing schedules as well. #Oncology #NCCN #SCC shorturl.at/O4c6o

In older postmenopausal women, leukocyte count was found to be an independent predictor of long #COVID symptom severity, highlighting its potential for use as a novel symptom biomarker. Learn more: bit.ly/43x8SED

#BREAKING: The #FDA has approved tenecteplase (TNKase; Genentech), a thrombolytic or clot-dissolving agent, for the treatment of adult patients with acute ischemic stroke — marking tenecteplase as the first #stroke medicine to be approved by the FDA in nearly 30 years. Learn more: bit.ly/4bxdEUH

The #FDA has approved label changes for buprenorphine extended-release injection, including alternative injection sites and a rapid initiation protocol, which stand as a major achievement in the treatment of patients with moderate to severe #opioid use disorder. Learn more: bit.ly/4kgPT7q

A next-generation molecular #COVID/#Flu multiplex test (Metrix; Aptitude Medical Systems, Inc) received emergency use authorization from the #FDA for detection of SARS-CoV-2, Influenza A virus, and Influenza B virus in 20 minutes. Learn more: bit.ly/4i9sR0j

AKF Chief Medical Officer @pranavgarimella.bsky.social sat down with @pharmacytimes.bsky.social to discuss the recent FDA approval of semaglutide to reduce kidney disease & cardiovascular death risks in adults with type 2 diabetes & chronic kidney disease. Watch the interview: bit.ly/41sSynb

There have been 68 confirmed human cases of #H5N1 reported by the CDC as of February 14, 2025; however, a recent study published by the agency suggests that this number is an undercount because of asymptomatic illness. Learn more: bit.ly/4gO3ss7

#Drugshortages are multifaceted, involving manufacturers, regulatory agencies, and health care providers, in a collaborative effort to identify and mitigate issues. All stakeholders should work together to determine and address drug shortages. Learn more: bit.ly/4k6fbEW

#BREAKING: Chikungunya vaccine (VimKunya; Bavarian Nordic A/S) was granted #FDA approval for patients aged 12 and older to prevent against #chikungunya virus (CHIKV) during travel. Learn more: bit.ly/3X3k0VG

RxPass, #Amazon Pharmacy’s subscription service for common medications, has demonstrated significant improvements in medication adherence and out-of-pocket cost reductions — making it difficult for retail pharmacies to compete with Amazon Pharmacy’s business model. Learn more: bit.ly/3EyHlIx

Mindfulness training groups could be recommended for those who have residual #opioid cravings and are receiving maintenance therapy with buprenorphine. Learn more: bit.ly/4jRsN7g

The demands of the #pharmacy profession—long hours, high stress, and emotional strain—can take a toll on pharmacists’ well-being. To sustain their ability to care for others, pharmacists must also care for themselves. Read more: bit.ly/3WOi2sl

Major #FDA news: Ranibizumab injection (Susvimo; Roche) 100 mg/mL administered through a port delivery platform (PDP) became the first and only FDA-approved continuous treatment to maintain vision in patients with #diabetic macular edema. Learn more: bit.ly/4gsyaqf

February 4th is World Cancer Day, a global initiative aimed at raising awareness, reducing stigma, and promoting equitable access to #cancer care, with pharmacy professionals playing a vital role in prevention, treatment, and support for patients and communities. Learn more: bit.ly/411O1Yw

Hello BlueSky! Pharmacy Times® offers the latest news and insights for the #pharmacy professional and solutions that impact the everyday practice of pharmacy. We are excited to share knowledge and connect with pharmacy professionals.